Hill-Rom Holdings Inc (HRC) Receives Analyst Rating

Hill-Rom Holdings Inc (HRC) : 6 analysts are covering Hill-Rom Holdings Inc (HRC) and their average rating on the stock is 1.75, which is read as a Buy. 3 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Hill-Rom Holdings Inc (HRC) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 2, which recommends a Buy affirms that they expect a large upside in the stock from the current levels. A total of 2 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

Hill-Rom Holdings Inc (HRC) : Currently there are 4 street experts covering Hill-Rom Holdings Inc (HRC) stock. The most bullish and bearish price target for the stock is $69 and $59 respectively for the short term. The average price target of all the analysts comes to $65.25. The estimated standard deviation from the target is $4.35.


Also, Equity analysts at the Brokerage firm Morgan Stanley upgrades its rating on Hill-Rom Holdings Inc (NYSE:HRC). The rating major has initiated the coverage with overweight rating on the shares. Earlier, the shares were rated a Equal-weight by the brokerage firm. The Analysts at Morgan Stanley raises the price target from $54 per share to $62 per share. The rating by the firm was issued on June 16, 2016.

Hill-Rom Holdings Inc (NYSE:HRC): After opening at $58.08, the stock dipped to an intraday low of $58.08 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $59.12 and the buying power remained strong till the end. The stock closed at $58.99 for the day, a gain of 1.60% for the day session. The total traded volume was 528,645. The stocks close on the previous trading day was $58.06.

Hill-Rom Holdings, Inc. (Hill-Rom) is a medical technology company. The Company partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. The Company operates in three segments: North America, Surgical and Respiratory Care and International. North America segment sells and rents its patient support and near-patient technologies and services, as well as its clinical workflow solutions, in the United States and Canada. Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products globally. International segment sells and rents similar products as its North America segment in regions outside of the United States and Canada.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *